Interpretable HER2 scoring by evaluating clinical guidelines through a weakly supervised, constrained deep learning approach.

Pham, Manh-Dan; Balezo, Guillaume; Tilmant, Cyprien; Petit, Stéphanie; Salmon, Isabelle; Hadj, Saïma Ben; Fick, Rutger H J

Pham, Manh-Dan; Balezo, Guillaume; Tilmant, Cyprien; Petit, Stéphanie; Salmon, Isabelle; Hadj, Saïma Ben; Fick, Rutger H J.

Affiliation

Pham MD; Tribun Health, 2 Rue du Capitaine Scott, 75015 Paris, France.
Balezo G; Tribun Health, 2 Rue du Capitaine Scott, 75015 Paris, France.
Tilmant C; GHICL, Lille, France.
Petit S; Xpath Nord, Leulinghem, France.
Salmon I; Hôpital Erasme, Route de Lennik 808 1070, Brussels, Belgium.
Hadj SB; Tribun Health, 2 Rue du Capitaine Scott, 75015 Paris, France.
Fick RHJ; Tribun Health, 2 Rue du Capitaine Scott, 75015 Paris, France. Electronic address: rfick@tribun.health.

Comput Med Imaging Graph ; 108: 102261, 2023 09.

Article in En | MEDLINE | ID: mdl-37356357

Subject(s)

Breast Neoplasms; Deep Learning; Humans; Female; In Situ Hybridization, Fluorescence/methods; Breast Neoplasms/pathology

Key words

Breast cancer; Deep Learning; Digital Pathology; HER2 scoring; Weakly supervised Constrained Optimization

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Deep Learning Type of study: Guideline / Prognostic_studies Limits: Female / Humans Language: En Journal: Comput Med Imaging Graph Journal subject: DIAGNOSTICO POR IMAGEM Year: 2023 Document type: Article Affiliation country: France Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google